Skip to main navigation
Supernus Pharmaceuticals

Header Links

  • Return to Supernus.com

Investor Relations

  • Overview
  • News & Events
    Press Releases Events & Presentations
  • Governance
    Corporate Governance Management Board of Directors Committee Composition Contact the Board
  • Financials & Filings
    Financials & Filings SEC Filings Annuals & Proxies Quarterly Results
  • Stock
    Stock Information Historic Stock Lookup Investment Calculator Ownership Profile
  • Contact Us

Investor Relations

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Governance
    • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials & Filings
    • Financials & Filings
    • SEC Filings
    • Annuals & Proxies
    • Quarterly Results
  • Stock
    • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Ownership Profile
  • Contact Us

    Breadcrumb

  1. Investor Relations
  2. Financials & Filings

Financials & Filings

Show all
2022
Second Quarter
  • Supernus Announces Second Quarter 2022 Financial Results
  • Form 10-Q


Annual Reports

Documents
  • Add Files
    2021 Annual Report 1.1 MB
  • Add Files
    2020 Annual Report 975.2 KB
  • Add Files
    2019 Annual Report 467 KB


Proxy Statements

Filing date View
May 2, 2022
0001104659-22-054642.pdf
0001104659-22-054642.rtf
0001104659-22-054642.xls
View HTML
May 2, 2022
0001104659-22-054617.pdf
0001104659-22-054617.rtf
0001104659-22-054617.xls
View HTML


Form 10-K

Filing date View
March 9, 2023 View HTML
0001356576-23-000016.pdf
0001356576-23-000016.rtf
0001356576-23-000016.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
March 2, 2023 View HTML
0001356576-23-000013.pdf
0001356576-23-000013.rtf
0001356576-23-000013.xls


Form 10-Q

Filing date View
November 9, 2022
0001356576-22-000076.pdf
0001356576-22-000076.rtf
0001356576-22-000076.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 8, 2022
0001356576-22-000057.pdf
0001356576-22-000057.rtf
0001356576-22-000057.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Shareholder Tools


Email Alerts


RSS Feeds


Search

Back to Top
Supernus Pharmaceuticals

Supernus Pharmaceuticals, Inc.
9715 Key West Avenue
Rockville, MD 20850
(301) 838-2500
info@supernus.com

Back to Top

© 2023 Supernus Pharmaceuticals

Post Footer Links

  • Sitemap
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • State Policy
  • Social Media Community Guidelines